SCHEMBL8695072

SCHEMBL8695072

NS(=O)(=O)c1cc(-c2cccnc2)ccc1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.56
CA9 Q16790 2/20 0.56
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
HTR6 P50406 1/20 0.49
PTGS2 P35354 1/20 0.48
CYP11B1 P15538 2/20 0.47
CYP11B2 P19099 2/20 0.47
CYP19A1 P11511 2/20 0.47
CYP17A1 P05093 1/20 0.47
MKNK1 Q9BUB5 3/20 0.47
MKNK2 Q9HBH9 3/20 0.47
CYP1A2 P05177 2/20 0.47
MEN1 O00255 1/20 0.45
PSIP1 O75475 1/20 0.45
AXL P30530 1/20 0.45
ERN1 O75460 1/20 0.44
KMO O15229 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29808069 0.81 CA2 (0.58) CA2CA9CA12CA1HTR6
SCHEMBL5488230 0.80 CA2 (0.56) CA2CA9CA12CA1PTGS2
SCHEMBL5624294 0.79 CA2 (0.59) CA2CA9CA12CA1HTR6
SCHEMBL29914888 0.78 HTR6 (0.61) CA2CA9CA12CA1HTR6
SCHEMBL19533217 0.74 CYP11B1 (0.56) PTGS2CYP11B1CYP11B2CYP19A1CYP17A1
SCHEMBL9974947 0.73 CYP2A6 (0.62) CA2CA9CA12CA1PTGS2
SCHEMBL9974924 0.73 CYP2A6 (0.62) CA2CA9CA12CA1PTGS2
SCHEMBL21742734 0.73 CYP11B1 (0.54) CYP11B1CYP11B2CYP19A1CYP17A1MKNK1
SCHEMBL14075569 0.73 CA9 (0.70) CA2CA9CA12CA1HTR6
SCHEMBL16805996 0.73 SLC2A1 (0.66) PTGS2CYP11B1CYP11B2CYP19A1CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998004260-A1 SUBSTITUTED BIPHENYL SULFONAMIDE ENDOTHELIN ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-02-05 WO disclosed